Description:
Human MHC class I antigens are expressed constitutively on all nucleated cells such as lymphocytes, thymocytes, granulocytes and bone marrow cells and are absent on erythrocytes. MHC class I antigens play a role in class I MHC-associated antigen presentation, inhibition of NK cell cytotoxicity, tumor surveillance and tissue allotransplantation. This clone also reacts strongly with primate cells.
Applications: Suitable for use in Flow Cytometry. Other applications not tested.
Recommended Dilutions: Optimal dilutions to be determined by the researcher.
Positive Control: Human lymphocytes, Tonsil and lymph nodes
Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. |
| Type | Isotype | Clone | Grade |
| Mab | IgG2a,k | 0.N.414 | Affinity Purified |
|
| Size | | Storage | Shipping | Source | Host |
| 500ul | | -20°C | Blue Ice | Human | Mouse |
|
| Concentration: |
| ~0.2mg/ml |
| Immunogen: |
| Human peripheral blood leukocytes. Cellular Localization: Cell membrane. |
| Purity: |
| Purified by Protein A affinity chromatography. |
| Form |
| Supplied as a liquid in PBS, pH 7.4, 0.2% BSA, 0.09% sodium azide. Also available without BSA and azide. See M3886-10X. |
| Specificity: |
| Recognizes a monomorphic determinant of human major histocompatibility (MHC) class I antigens (HLA-A, B and C). Species Crossreactivity: primates |
|
| Intended for research use only. Not for use in human, therapeutic, or diagnostic applications. |
US Biological application references: 1. Nozaki, K. and Pestronk, A. (2009) J Neurol Neurosurg Psychiatry 80:904-908. 2. Miller, T. et al., (2002) J Neurol Neurosurg Psychiatry 73:420-428. 3. Temiz, P. et al., (2009) J Neurol Sci. 278:25-29. 1. Young, N.T., et al., Hum. Immunol. 52: 1-11 (1997). 2. Krensky, A.M., et al., Transplant Proc. 28: 3026-3028 (1996). 3. Hansen, J.A., et al., Hematol. Oncol. Clin. North Am. 4: 507-515 (1990). |
|